Sanofi (SNY) Receivables (2016 - 2025)
Historic Receivables for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $11.5 billion.
- Sanofi's Receivables rose 1810.11% to $11.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.5 billion, marking a year-over-year increase of 1810.11%. This contributed to the annual value of $11.2 billion for FY2025, which is 1319.14% up from last year.
- Sanofi's Receivables amounted to $11.5 billion in Q4 2025, which was up 1810.11% from $8.8 billion recorded in Q2 2025.
- Sanofi's 5-year Receivables high stood at $11.5 billion for Q4 2025, and its period low was $8.2 billion during Q2 2021.
- In the last 5 years, Sanofi's Receivables had a median value of $9.4 billion in 2021 and averaged $9.5 billion.
- In the last 5 years, Sanofi's Receivables tumbled by 830.15% in 2024 and then skyrocketed by 1810.11% in 2025.
- Quarter analysis of 5 years shows Sanofi's Receivables stood at $9.6 billion in 2021, then increased by 3.46% to $9.9 billion in 2022, then increased by 7.28% to $10.6 billion in 2023, then decreased by 8.3% to $9.7 billion in 2024, then grew by 18.1% to $11.5 billion in 2025.
- Its Receivables was $11.5 billion in Q4 2025, compared to $8.8 billion in Q2 2025 and $9.7 billion in Q4 2024.